| Product Code: ETC10765533 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Nigeria continued to rely on imports of pemetrexed, with top exporters being India, China, Netherlands, Metropolitan France, and USA. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a significant compound annual growth rate (CAGR) decline of -26.13% from 2020 to 2024, the negative growth rate of -30.33% in 2023-24 suggests a challenging market environment. Monitoring market dynamics and exploring strategies to stimulate demand will be crucial for stakeholders in the Nigerian pemetrexed import market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Pemetrexed Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Pemetrexed Market - Industry Life Cycle |
3.4 Nigeria Pemetrexed Market - Porter's Five Forces |
3.5 Nigeria Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Nigeria Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Nigeria Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Nigeria Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Nigeria Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Nigeria Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Nigeria Pemetrexed Market Trends |
6 Nigeria Pemetrexed Market, By Types |
6.1 Nigeria Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Nigeria Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Nigeria Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Nigeria Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Nigeria Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Nigeria Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Nigeria Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Nigeria Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Nigeria Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Nigeria Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Nigeria Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Nigeria Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Nigeria Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Nigeria Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Nigeria Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Nigeria Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Nigeria Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Nigeria Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Nigeria Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Nigeria Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Nigeria Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Nigeria Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Nigeria Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Nigeria Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Nigeria Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Nigeria Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Nigeria Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Nigeria Pemetrexed Market Import-Export Trade Statistics |
7.1 Nigeria Pemetrexed Market Export to Major Countries |
7.2 Nigeria Pemetrexed Market Imports from Major Countries |
8 Nigeria Pemetrexed Market Key Performance Indicators |
9 Nigeria Pemetrexed Market - Opportunity Assessment |
9.1 Nigeria Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Nigeria Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Nigeria Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Nigeria Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Nigeria Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Nigeria Pemetrexed Market - Competitive Landscape |
10.1 Nigeria Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here